SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway

• Rie Matsushima-Nishiwaki,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  ⨯
• Noriko Yamada,

  Roles Investigation, Visualization

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  ⨯
• Yuria Hattori,

  Roles Investigation

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  ⨯
• Yui Hosokawa,

  Roles Investigation

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  ⨯
• Junko Tachi,

  Roles Investigation

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  ⨯
• Takamitsu Hori,

  Roles Investigation

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  ⨯
• Osamu Kozawa

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: okkasugai@yahoo.co.jp

  Affiliation Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan

  https://orcid.org/0000-0002-4834-6073

  ⨯